SUDD Activators are a diverse array of chemical compounds that indirectly enhance the functional activity of SUDD by modulating various cellular signaling pathways. Forskolin and IBMX, both affecting levels of cyclic nucleotides, lead to an increase in cAMP or cGMP, which activates protein kinase A or protein kinase G, respectively. This activation can result in phosphorylation events that enhance the activity of SUDD if it is involved in these kinase pathways. Similarly, sphingosine-1-phosphate and A23187 can potentiate SUDD activity by modulating G-protein-coupled receptor signaling and increasing intracellular calcium levels, which are crucial for various calcium-dependent processes that mayinclude SUDD. Thapsigargin, by inhibiting the SERCA pump, also elevates cytosolic calcium levels, which could activate calcium-dependent signaling pathways, potentially enhancing the activation of SUDD through such mechanisms. In addition, PMA, acting as a PKC activator, could initiate a cascade of phosphorylation events and if SUDD is a substrate or regulator in this pathway, its activity would be enhanced.
The activity of SUDD may also be influenced by inhibitors such as LY294002, U0126, PD98059, and Staurosporine. LY294002 inhibits the PI3K/AKT pathway, which could lead to the enhancement of SUDD's activity by modulating downstream targets within this pathway. MEK inhibitors U0126 and PD98059 could potentially enhance SUDD activity by altering the MAPK/ERK pathway's phosphorylation patterns, suggesting that if SUDD is regulated by this pathway, its activity would be indirectly increased by these compounds. Staurosporine, despite its broad-spectrum kinase inhibitory effects, could result in selective enhancement of SUDD pathways by inhibiting negative regulators of SUDD. Lastly, Genistein and Epigallocatechin gallate (EGCG) can enhance SUDD activity by inhibiting tyrosine kinases and other kinases, respectively, which could otherwise competitively suppress the pathways in which SUDD is active, thereby lifting these inhibitory effects and potentially enhancing the functional activity of SUDD.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin stimulates adenylate cyclase, resulting in an increase in cyclic AMP (cAMP) levels, which can enhance SUDD activity if SUDD is responsive to cAMP-dependent protein kinase A (PKA) signaling. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which may enhance SUDD activity through PKC-mediated phosphorylation events if SUDD is part of the PKC signaling cascade. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin increases intracellular calcium levels, potentially leading to the activation of calcium-dependent protein kinases that could enhance SUDD activity through phosphorylation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin triggers the PI3K/Akt signaling pathway, potentially enhancing SUDD activity if SUDD is regulated by components downstream of Akt, such as mTOR or GSK3. | ||||||
NAD+, Free Acid | 53-84-9 | sc-208084B sc-208084 sc-208084A sc-208084C sc-208084D sc-208084E sc-208084F | 1 g 5 g 10 g 25 g 100 g 1 kg 5 kg | $57.00 $191.00 $302.00 $450.00 $1800.00 $3570.00 $10710.00 | 4 | |
NAD+ serves as a substrate for sirtuins, which, if SUDD activity is sirtuin-dependent, could enhance SUDD via deacetylation of specific lysine residues. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium Chloride inhibits GSK-3, potentially enhancing SUDD activity if SUDD is regulated by GSK-3 through phosphorylation. | ||||||
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol, as a beta-adrenergic agonist, can increase cAMP levels, potentially enhancing SUDD activity if SUDD is modulated by cAMP-dependent pathways. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic Acid modulates gene expression through retinoic acid receptors, which could enhance SUDD activity if SUDD is regulated by genes responsive to these transcriptional changes. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $37.00 $69.00 $109.00 $218.00 $239.00 $879.00 $1968.00 | 47 | |
Curcumin can modulate NF-κB signaling, potentially enhancing SUDD activity if SUDD is regulated by NF-κB-dependent transcriptional events. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol activates sirtuins, which could enhance SUDD activity if SUDD is sensitive to sirtuin-mediated deacetylation processes. | ||||||